ProfileGDS4718 / 227983_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 72% 88% 65% 69% 73% 80% 71% 73% 73% 68% 82% 71% 76% 76% 81% 75% 74% 88% 93% 62% 72% 72% 73% 73% 78% 74% 75% 69% 85% 87% 81% 71% 66% 81% 79% 82% 80% 74% 90% 73% 81% 87% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0223472
GSM549102patient 115, normal, homogenized [OPG study]7.0299572
GSM549104patient 119, normal, homogenized [OPG study]8.9223888
GSM549108patient 138, normal, homogenized [OPG study]6.4980465
GSM549119patient 077, normal, homogenized [OPG study]6.7623569
GSM549133patient 032, cancer, homogenized [OPG study]7.2630773
GSM549139patient 042, cancer, homogenized [OPG study]7.8773880
GSM549099patient 107, normal, homogenized [OPG study]6.8996371
GSM549109patient 139, normal, homogenized [OPG study]7.1423773
GSM549110patient 046, normal, homogenized [OPG study]7.0764773
GSM549114patient 063, normal, homogenized [OPG study]6.6835968
GSM549122patient 082, normal, homogenized [OPG study]8.0420882
GSM549134patient 033, cancer, homogenized [OPG study]7.0039171
GSM549136patient 036, cancer, homogenized [OPG study]7.5306576
GSM549140patient 044, cancer, homogenized [OPG study]7.5497676
GSM549111patient 047, normal, homogenized [OPG study]8.0178881
GSM549113patient 057, normal, homogenized [OPG study]7.3847675
GSM549132patient 031, cancer, homogenized [OPG study]7.2669874
GSM549137patient 038, cancer, homogenized [OPG study]8.8635688
GSM549142patient 047, cancer, homogenized [OPG study]9.1663593
GSM549100patient 110, normal, homogenized [OPG study]6.2282662
GSM549107patient 135, normal, homogenized [OPG study]7.0058572
GSM549115patient 068, normal, homogenized [OPG study]7.1264672
GSM549116patient 072, normal, homogenized [OPG study]7.16673
GSM549120patient 078, normal, homogenized [OPG study]7.1367973
GSM549131patient 030, cancer, homogenized [OPG study]7.7511678
GSM549118patient 074, normal, homogenized [OPG study]7.283374
GSM549129patient 027, cancer, homogenized [OPG study]7.3620575
GSM549123patient 088, normal, homogenized [OPG study]6.823469
GSM549124patient 006, cancer, homogenized [OPG study]8.4004285
GSM549126patient 015, cancer, homogenized [OPG study]8.7463487
GSM549128patient 025, cancer, homogenized [OPG study]8.0851181
GSM549103patient 117, normal, homogenized [OPG study]6.9165771
GSM549117patient 073, normal, homogenized [OPG study]6.4923466
GSM549138patient 041, cancer, homogenized [OPG study]7.9859781
GSM549141patient 045, cancer, homogenized [OPG study]7.8280179
GSM549130patient 028, cancer, homogenized [OPG study]8.0086382
GSM549101patient 111, normal, homogenized [OPG study]7.7828480
GSM549105patient 128, normal, homogenized [OPG study]7.2415874
GSM549106patient 134, normal, homogenized [OPG study]9.3217590
GSM549112patient 048, normal, homogenized [OPG study]7.1095173
GSM549125patient 011, cancer, homogenized [OPG study]7.8852481
GSM549127patient 024, cancer, homogenized [OPG study]8.6703287
GSM549135patient 035, cancer, homogenized [OPG study]7.6697277